{"id":"W2609045359","doi":"10.1016/j.ahj.2017.04.008","title":"Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":293,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Canadian Institutes of Health Research; Novo Nordisk Fonden","keywords":"Medicine; Apixaban; Atrial fibrillation; Cardiology; Internal medicine; Reduction (mathematics); Embolism; Clinical trial; Rivaroxaban; Warfarin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02959055,0.002678104,0.004138094,0.0008762075,0.001361322,0.003865003,0.001613995,0.003568013,0.009191092],"category_scores_gemma":[0.02408465,0.001821401,0.003333681,0.0008958037,0.00255053,0.001528188,0.001268631,0.005531043,0.002566124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009764206,"about_ca_system_score_gemma":0.003651297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004187478,"about_ca_topic_score_gemma":0.00076962,"domain_scores_codex":[0.9832515,0.01158477,0.001674777,0.001518573,0.001238237,0.0007322075],"domain_scores_gemma":[0.9942841,0.002147092,0.001137799,0.0008472718,0.0005813226,0.001002396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.8039192,0.007029234,0.01416753,0.01072592,0.01299619,0.0005964268,0.0006416548,0.00348414,0.004484852,0.03691256,0.01644511,0.08859714],"study_design_scores_gemma":[0.8681746,0.03149371,0.01208094,0.002630766,0.01157747,0.0004105683,0.0001722042,0.003864782,0.001651167,0.02464321,0.04305797,0.0002425892],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.2633274,0.06884341,0.04672861,0.04336951,0.01786209,0.481891,0.01609173,0.000640062,0.06124625],"genre_scores_gemma":[0.6046884,0.01024312,0.04839662,0.02014061,0.006961396,0.2988537,0.003765421,0.0001273003,0.006823415],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.02959055,"threshold_uncertainty_score":0.1564916,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.107387908043509,"score_gpt":0.3791721058101254,"score_spread":0.2717841977666164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}